NCT07646262

Brief Summary

This study aims to evaluate the effects of different dietary interventions, including gluten-free, Mediterranean, and control diets, on disease activity, quality of life, and dietary inflammatory index in patients with rheumatoid arthritis. Participants will be followed for 12 weeks, and changes in clinical and nutritional outcomes will be assessed.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
2mo left

Started Oct 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress75%
Oct 2025Aug 2026

Study Start

First participant enrolled

October 29, 2025

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

June 9, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 12, 2026

Completed
18 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2026

Last Updated

June 12, 2026

Status Verified

June 1, 2026

Enrollment Period

8 months

First QC Date

June 9, 2026

Last Update Submit

June 9, 2026

Conditions

Keywords

Rheumatoid arthritisMediterranean dietGluten-free dietDietary inflammatory index (DII)Disease activity (DAS28)

Outcome Measures

Primary Outcomes (1)

  • Disease Activity (DAS28)

    Change in Disease Activity Score 28 (DAS28) from baseline to 12 weeks. Disease activity will be assessed using the DAS28 scoring system to evaluate changes in rheumatoid arthritis activity following dietary interventions.

    12 weeks

Secondary Outcomes (1)

  • Quality of Life (SF-12)

    Baseline 12 weeks

Study Arms (3)

Gluten-Free Diet Group

EXPERIMENTAL

Participants will follow a gluten-free diet for 12 weeks. All gluten-containing foods will be eliminated, and dietary guidance will be provided throughout the intervention period.

Behavioral: Gluten-Free Diet Group

Mediterranean Diet Group

EXPERIMENTAL

Participants will follow a Mediterranean diet for 12 weeks, emphasizing high intake of fruits, vegetables, whole grains, legumes, olive oil, and fish, with limited processed foods.

Behavioral: Mediterranean Diet

Control Diet Group

ACTIVE COMPARATOR

Participants will continue their usual diet without specific dietary modifications. General dietary advice may be provided but no structured intervention will be implemented.

Behavioral: Control Diet

Interventions

Participants will follow a gluten-free diet in which all wheat, barley, rye, and their derivatives are eliminated for 12 weeks. The diet focuses on naturally gluten-free foods such as fruits, vegetables, legumes, meat, fish, rice, and corn.

Gluten-Free Diet Group

Participants will follow a Mediterranean dietary pattern characterized by high intake of fruits, vegetables, whole grains, legumes, olive oil, and fish, with moderate consumption of dairy and low intake of red meat and processed foods for 12 weeks.

Mediterranean Diet Group
Control DietBEHAVIORAL

Participants will continue their habitual diet without any specific dietary restrictions or structured dietary guidance during the 12-week study period.

Control Diet Group

Eligibility Criteria

Age19 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of rheumatoid arthritis according to ACR/EULAR criteria Age between 19-65 years Stable medication regimen for at least 3 months prior to enrollment Willingness to comply with dietary interventions and study procedures Ability to provide informed consent

You may not qualify if:

  • Pregnancy or lactation Presence of other autoimmune or inflammatory diseases (e.g., SLE, IBD) Severe comorbidities (e.g., advanced cardiovascular, renal, or hepatic disease) Use of special diets (e.g., gluten-free diet) in the last 3 months Recent change in biologic or corticosteroid therapy (\<3 months) Food allergies or intolerances affecting dietary intervention adherence Inability to comply with dietary protocol or follow-up visits

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NCR International Hospital

Gaziantep, Şehitkamil, 27560, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Arthritis, Rheumatoid

Interventions

Diet, Mediterranean

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Diet, Plant-BasedDiet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Central Study Contacts

Nilüfer Gürsel, PhD

CONTACT

Mine Yurttagül, Prof. Dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Three parallel groups will receive different dietary interventions (gluten-free, Mediterranean, and control diets) over a 12-week period.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 9, 2026

First Posted

June 12, 2026

Study Start

October 29, 2025

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

August 31, 2026

Last Updated

June 12, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

IPD will not be publicly shared due to privacy and ethical restrictions.

Locations